Hermetica Superfood Encyclopedia
The Short Answer
Combretum imberbe contains triterpenoids (including pentacyclic types with MICs as low as 63 μg/mL against Staphylococcus aureus), flavonoids such as quercitrin and kaempferol, and high-density tannins and phenolics (172–851 mg GAE/g in leaves) that collectively drive antibacterial, antioxidant, and antiparasitic activities. The most quantified preclinical finding is an IC₅₀ of 1.25 μg/mL for stem methanol extract against Plasmodium falciparum in vitro, though no human clinical trial evidence exists to establish therapeutic dosing or confirmed efficacy in people.
CategoryHerb
GroupAfrican
Evidence LevelPreliminary
Primary KeywordCombretum imberbe benefits
Leadwood — botanical close-up
Health Benefits
**Antidiarrheal Activity**
Traditionally used in Tanzanian ethnomedicine to manage diarrhea, with tannins and phenolics likely reducing intestinal motility and exerting astringent effects on gut mucosa; no controlled human trial data are available to confirm this effect.
**Antimicrobial Action**
Triterpenoid isolates from leaves demonstrate minimum inhibitory concentrations of 63–93 μg/mL against Staphylococcus aureus, and acetone, ethanol, and water leaf extracts show measurable inhibition of enteric pathogens in vitro.
**Antiplasmodial Potential**: Stem methanol extract achieves an IC₅₀ of 1
25 μg/mL against Plasmodium falciparum, and ethanol extracts of leaves, root bark, and stem bark achieve IC₅₀ values near 4.0 μg/mL against the chloroquine-resistant K1 strain in cell-based assays.
**Antioxidant Properties**
Leaf and stem extracts contain phenolic compounds at 172–851 mg GAE/g and 35–350 mg GAE/g respectively, contributing to DPPH free radical scavenging capacity; notably, ash extracts display an inverse concentration-response relationship suggesting complex redox behavior.
**Anti-inflammatory Effects**
Flavonoids including catechin, epicatechin, and gallocatechin identified in C. imberbe extracts are associated with modulation of inflammatory mediators in related Combretum species, though specific enzymatic targets have not been characterized for this species.
**Antischistosomal Use**: Indigenous communities in southern Africa apply C
imberbe preparations for treatment of schistosomiasis, consistent with the broader antiparasitic activities documented across the Combretaceae family, though mechanistic and clinical data specific to this species are lacking.
**Wound-Healing and Antimycobacterial Applications**
Bark and leaf extracts are applied topically in traditional practice for wound management and are screened for activity against Mycobacterium species, supported by the extract's broad-spectrum antimicrobial phytochemistry including saponins and steroids.
Origin & History
Natural habitat
Combretum imberbe, commonly called the leadwood tree, is native to sub-Saharan Africa, distributed across southern and eastern Africa including Tanzania, Zimbabwe, Botswana, South Africa, and Mozambique. It thrives in low-altitude woodland, riverine forest margins, and savanna ecosystems, often on alluvial soils near seasonal watercourses. The tree is not commercially cultivated for medicinal purposes; all documented traditional and research use draws on wild-harvested bark, leaves, stems, and roots.
“Combretum imberbe holds cultural significance across southern and eastern Africa, where the leadwood tree is recognized not only medicinally but also spiritually and practically—its extremely dense, slow-burning wood has been used for fires, charcoal, and structural purposes for centuries. Indigenous communities in Tanzania, Zimbabwe, South Africa, and Mozambique have incorporated bark, leaf, and root preparations into traditional healing systems for diarrhea, wound infections, inflammatory conditions, and parasitic diseases including schistosomiasis. Preparations are typically prepared by healers through aqueous decoction or infusion of dried plant parts, with oral or topical administration depending on the condition treated, and ashes are occasionally used as wound dressings. No written historical pharmacopoeial records predate modern ethnobotanical surveys, but oral tradition and contemporary ethnobotanical documentation confirm widespread and sustained use across multiple ethnic and linguistic groups in the region.”Traditional Medicine
Scientific Research
The evidence base for Combretum imberbe consists exclusively of in vitro phytochemical and bioassay studies; no human clinical trials, animal pharmacology dose-response studies, or pharmacokinetic investigations have been published in the available literature. Key in vitro findings include antiplasmodial IC₅₀ values of 1.25 μg/mL (stem methanol extract) and 4.0 μg/mL (leaf/bark ethanol extracts) against Plasmodium falciparum, and antibacterial MICs of 63–93 μg/mL for isolated triterpenoids against Staphylococcus aureus. Leaf extracts tested against Caenorhabditis elegans at 0.5–1 mg/mL showed no antiparasitic activity, highlighting species-specific and concentration-dependent limitations. The overall evidence is preliminary, lacks sample sizes or validated human outcome measures, and cannot be used to establish therapeutic claims without further controlled investigation.
Preparation & Dosage
Traditional preparation
**Traditional Decoction (Bark/Leaf)**
Dried bark or leaves are boiled in water for 15–30 minutes and consumed orally for antidiarrheal or anti-inflammatory purposes; no standardized volumes or concentrations are documented.
**Ethanol Extract (Research Grade)**
Used at 31.25–250 μg/mL in in vitro assays; no human oral dose equivalent has been derived or validated.
**Methanol Extract (Research Grade)**
Stem methanol extracts tested at concentrations yielding IC₅₀ of 1.25 μg/mL against P. falciparum in cell culture; not translatable to human dosing without pharmacokinetic data.
**70% Aqueous Acetone Extract**
172–851 mg GAE/g in leaves); not a traditional preparation form
Used in phytochemical screening of phenolic and tannin content (.
**Topical Ash Poultice**
0–43 mg GAE/g) than leaf or stem extracts
Plant ash containing saponins and terpenoids is applied to wounds in some indigenous practices; phenolic content in ash is markedly lower (.
**Standardization**
No commercial standardized extract exists; no active marker compounds are defined for quality control purposes in any supplement context.
Nutritional Profile
Combretum imberbe is not consumed as a food ingredient and has no characterized macronutrient or micronutrient profile relevant to nutrition. Phytochemically, leaves are the richest documented source, containing total phenolics of 172–851 mg gallic acid equivalents per gram of extract depending on solvent polarity, with stems yielding 35–350 mg GAE/g and ash fractions yielding 0–43 mg GAE/g. Identified flavonoids include quercitrin, kaempferol, catechin, epicatechin, and gallocatechin; tannins are prominent in 70% aqueous acetone fractions. Additional chemical classes include saponins, steroids, amino acids, and triterpenoids such as pentacyclic oleanane-type acids. Bioavailability of these compounds from crude extracts has not been assessed in any published pharmacokinetic study, and absorption, distribution, metabolism, and excretion parameters are entirely unknown for human consumers.
How It Works
Mechanism of Action
Triterpenoids from C. imberbe, including 1α,23-dihydroxy-12-oleanen-29-oic acid and related pentacyclic structures, are hypothesized to disrupt bacterial cell membrane integrity, consistent with their low MIC values against Staphylococcus aureus and enteric organisms, though direct membrane permeability assays for this species have not been published. Flavonoids such as quercitrin and kaempferol likely exert antioxidant effects through hydrogen atom transfer and single electron donation to neutralize reactive oxygen species, while catechins may additionally chelate transition metals that catalyze oxidative damage. Tannins contribute astringent and antibacterial properties by precipitating proteins in bacterial cell walls and reducing mucosal fluid secretion, which mechanistically supports the traditional antidiarrheal indication. Anti-inflammatory and antiparasitic mechanisms remain inferential, extrapolated from structurally similar Combretum species where flavonoid-mediated inhibition of cyclooxygenase enzymes and interference with parasite electron transport chains have been proposed but not confirmed for C. imberbe specifically.
Clinical Evidence
No clinical trials in human subjects have been conducted on Combretum imberbe for any indication, including its primary traditional use as an antidiarrheal agent. All quantified outcomes derive from in vitro cell-based and microbial assays, which provide mechanistic hypotheses but cannot establish efficacy, safe dosing, or risk-benefit profiles in people. The most robust data point—an IC₅₀ of 1.25 μg/mL against Plasmodium falciparum—comes from a single cell culture assay without pharmacokinetic validation of whether such concentrations are achievable or safe in vivo. Confidence in any clinical application remains very low, and formal clinical development would require progression through animal toxicology, pharmacokinetic studies, and phased human trials before any therapeutic conclusions can be drawn.
Safety & Interactions
No formal human safety data, established LD₅₀ values, or adverse event reports exist for Combretum imberbe extracts or preparations; all available safety inferences derive from traditional use patterns suggesting low acute oral toxicity at customary decoction doses. High tannin content raises theoretical concerns about gastrointestinal irritation, reduced absorption of iron and other minerals, and potential hepatotoxicity with chronic high-dose exposure, consistent with known tannin pharmacology across plant species. No drug interaction studies have been conducted, but the presence of bioactive flavonoids and triterpenoids creates a theoretical basis for interactions with anticoagulants, antimalarial drugs, and hepatically metabolized medications via cytochrome P450 modulation, as seen with structurally related compounds in other plants. Pregnancy and lactation safety is entirely uncharacterized, and use during these periods should be avoided pending formal toxicological evaluation; no maximum safe dose has been established for any route of administration.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
Combretum imberbe WawraLeadwood treeHardleaf leadwoodAppelblaar (Afrikaans)Mbambakofi (Swahili)
Frequently Asked Questions
What is Combretum imberbe used for in traditional medicine?
Combretum imberbe is traditionally used across southern and eastern Africa—including Tanzania, Zimbabwe, and South Africa—as an antidiarrheal, wound-healing, anti-inflammatory, and antiparasitic remedy. Preparations include aqueous decoctions of bark and leaves taken orally for diarrhea and gut infections, and ash poultices applied topically for wounds. It is also used in some communities against schistosomiasis, reflecting its broad-spectrum antimicrobial phytochemistry.
Does Combretum imberbe have any proven antiplasmodial activity?
In vitro studies report that stem methanol extracts of Combretum imberbe achieve an IC₅₀ of 1.25 μg/mL against Plasmodium falciparum, and leaf/bark ethanol extracts reach IC₅₀ values near 4.0 μg/mL against the chloroquine-resistant K1 strain. These results are promising at the cell-culture level but have not been validated in animal models or human clinical trials, so they cannot be translated into clinical antimalarial recommendations at this time.
What bioactive compounds are found in Combretum imberbe?
The main bioactive classes identified in C. imberbe include triterpenoids (such as 1α,23-dihydroxy-12-oleanen-29-oic acid and pentacyclic oleanane-type acids), flavonoids (quercitrin, kaempferol, catechin, epicatechin, gallocatechin), tannins, saponins, steroids, and amino acids. Leaf extracts are particularly rich in phenolics, measuring 172–851 mg gallic acid equivalents per gram depending on extraction solvent. These compounds collectively underpin the plant's documented antimicrobial, antioxidant, and antiparasitic activities in laboratory studies.
Is Combretum imberbe safe to use, and are there any drug interactions?
Formal human safety data for Combretum imberbe are absent; no LD₅₀, clinical adverse event data, or drug interaction studies have been published. High tannin content theoretically risks gastrointestinal irritation and interference with dietary iron absorption, and bioactive flavonoids may interact with hepatically metabolized drugs via cytochrome P450 pathways. Until rigorous toxicological and interaction studies are completed, use in pregnancy, lactation, or alongside prescription medications should be avoided.
What dose of Combretum imberbe is recommended for supplementation?
No standardized supplemental dose exists for Combretum imberbe, and no commercial standardized extract is available. Research studies use crude extracts at concentrations of 31.25–250 μg/mL for in vitro testing, but these cannot be converted to human oral doses without pharmacokinetic data on absorption and bioavailability. Traditional practitioners prepare oral decoctions from dried bark or leaves without measured concentrations, and no dose-response data from human studies are available to guide safe or effective dosing.
What is the evidence quality for Combretum imberbe's antidiarrheal effects?
While Combretum imberbe has been traditionally used in Tanzanian ethnomedicine to manage diarrhea, there are currently no controlled human clinical trials validating this effect. The proposed mechanism involves tannins and phenolic compounds reducing intestinal motility and exerting astringent effects on the gut lining, but these mechanisms have only been demonstrated in traditional use and preliminary laboratory studies. More rigorous clinical research is needed to establish safety and efficacy for this indication.
Does Combretum imberbe have antimicrobial properties, and how strong are they?
Triterpenoid isolates extracted from Combretum imberbe leaves have demonstrated antimicrobial activity with minimum inhibitory concentrations ranging from 63–93 μg/mL, suggesting moderate potency against tested microbial strains. However, these findings are from laboratory studies and do not directly translate to antimicrobial effects in the human body. Additional research is needed to determine whether these compounds remain bioactive when the plant is taken as a whole-herb supplement.
Who might benefit most from using Combretum imberbe as a traditional remedy?
Individuals seeking traditional support for gastrointestinal complaints, particularly diarrhea in populations with historical ethnomedicinal use (such as in Tanzania), may consider Combretum imberbe based on traditional practice. However, those with chronic diarrhea, inflammatory bowel conditions, or constipation should consult a healthcare provider before use, as the astringent and motility-reducing properties may not be appropriate for all gastrointestinal conditions. Given the lack of human clinical data, it is best used under guidance from a practitioner familiar with traditional herbal medicine.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w combretum-imberbe-leadwood-tree curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
